Starting an Ambulatory Surgery Center: The Orthopedic Surgeon's Development Playbook

There are two ways to participate in ASC ownership: buy into an established facility (see ASC Ownership: The Orthopedic Wealth Lever) or develop a new one from scratch. De novo development is a fundamentally different undertaking — bigger capital commitment, longer timeline, more regulatory complexity — but it also means the group controls the governance, the case mix, the technology choices, and the distribution model from day one.

For orthopedic groups with the volume, the capital, and the patience to see it through, a well-executed de novo ASC may be the highest-return financial project of a career. The 2026 CMS expansion of the ASC Covered Procedures List by 547 procedures — including additional joint replacement and spine procedures that had been inpatient-only — makes the economics more attractive than ever.¹

This guide covers what it actually takes to get from concept to first case.

Is your group ready? Prerequisites to assess first

Before you engage a healthcare attorney or architect, assess these prerequisites honestly:

• Volume. A financially viable orthopedic ASC typically requires 1,500–3,000+ cases per year at stabilization. That requires a core group of 6–12 surgeons with high-volume subspecialties (spine, joint replacement, sports medicine, hand). Smaller groups with lower-volume subspecialties should model break-even carefully.
• Case mix and payer mix. ASC economics depend on commercial insurance reimbursement. If your group's case mix skews heavily toward Medicaid or workers' comp, the revenue per case drops materially. Target >60% commercial insurance cases for a viable facility.
• Regulatory environment. Certificate of Need (CON) laws in roughly half of U.S. states require regulatory approval before you can open an ASC. If you're in a CON state, add 6–18 months and significant legal fees before you can break ground.
• Group cohesion. De novo ASC development will stress a physician group. Capital calls, governance disagreements, and the two-year pre-distribution period have ended partnerships. If your group can't agree on partnership buy-in terms for the practice, don't start a $5M construction project together.

Certificate of Need: know your state before planning anything

CON laws require a state regulatory body to approve any new healthcare facility before it can be developed. The intent is to prevent duplicative capacity; the effect is a significant barrier to new ASC formation. Approximately 30 states currently require CON approval for new ASCs, though the regulatory landscape is shifting with multiple states reforming or eliminating their CON programs in 2025–2026.²

Non-CON states (ASC can be developed without prior regulatory approval, subject to normal licensure): Texas, Florida, Arizona, Colorado, Utah, Montana, Wyoming, Idaho, Kansas, South Dakota, North Dakota, Michigan, Pennsylvania, California, and others. Verify current status with a healthcare attorney — reform is ongoing.

CON states (state approval required before opening): New York, New Jersey, Massachusetts, Maryland, Virginia, North Carolina, Georgia, Tennessee, Kentucky, West Virginia, Illinois, Wisconsin, Iowa, and others. Several states have active CON reform legislation in 2026.

In CON states, the application process involves demonstrating "community need," financial viability, and absence of duplicative capacity. Competitors (including existing ASCs and hospitals) have the right to oppose your application. Approval timelines range from 6 months in cooperative states to 18+ months in contested proceedings. Legal fees for CON litigation can reach six figures. Engaging a healthcare attorney with CON experience in your specific state is essential before committing any capital.

Facility planning and development costs

A full orthopedic ASC typically requires 8,000–20,000 sq ft depending on the number of operating rooms, the case mix, and whether you're including prep/recovery bays, a central sterile processing department, and ancillary services like imaging. Typical configurations for an orthopedic-focused de novo ASC:

Construction costs for purpose-built orthopedic ASC space run $250–$500/sq ft depending on region, finishes, and OR infrastructure requirements. High-complexity orthopedic ORs (joint replacement, spine) require more robust structural support, larger rooms, laminar airflow, and specialized gas/suction infrastructure.

Equipment is a major variable. A conventional ortho OR set costs $500K–$1M to equip. A robotics-enabled joint replacement OR (Mako, ROSA, or equivalent) adds $1M–$2M per system, though manufacturers often provide usage-based or revenue-share arrangements that reduce upfront capital. Budget equipment at $750K–$2.5M depending on subspecialty mix and robotics strategy.

Working capital to cover the first 6–9 months of operations before billing revenue stabilizes: $500K–$1.5M.

Capital structure and physician syndication

Most physician-developed ASCs are structured as LLCs or LPs with each founding surgeon purchasing an ownership unit. The capital structure is typically determined by dividing total development cost by the number of founding surgeon-owners, with provisions for additional physician partners to be added later at a formula price.

For a $5M development with 10 surgeon-owners: each surgeon contributes $500K. That capital is typically called in tranches over the 18–24 month development period — not all at once. A surgeon earning $800K/year with good cash-flow management can fund this contribution, but it requires explicit financial planning. The capital contribution period is also the period of zero distributions: you're writing checks with no incoming facility revenue.

Anti-Kickback Statute safe harbor. For an ASC to bill Medicare, the physician-ownership structure must fall within a federal safe harbor under 42 C.F.R. § 1001.952(r). The key requirements: each physician-owner must be a surgeon who uses the ASC, ownership terms must be based on fair market value, and the ASC must not condition ownership on referral volume. Surgeon-owned single-specialty ASCs (all owners are orthopedic surgeons) have the cleanest safe harbor pathway. Multi-specialty ASCs have additional requirements. Healthcare transaction attorneys structure these arrangements; don't DIY it.³

Development financing options

Few orthopedic groups fund a de novo ASC entirely from physician equity. Common financing approaches:

• Conventional commercial bank loan. Lenders with healthcare experience (e.g., Live Oak Bank, Fifth Third Healthcare, Bank of America Healthcare) will finance 50–70% of ASC development costs. Requires personal guarantees from physician-owners, evidence of projected case volume, and physician financial strength. Loan terms: 10–15 year amortization, floating or fixed rates.
• SBA 7(a) loans up to $5M for the operating entity. Useful for smaller facilities; requires standard SBA documentation and 10% equity injection.
• Corporate partner equity. A management company or hospital system invests capital in exchange for a minority ownership stake (typically 30–50%) and a management services agreement. The physicians retain majority control and receive the majority of distributions, but give up governance purity. Major ASC operators (USPI, Surgery Partners, AmSurg) actively develop new facilities with surgeon groups in this model. This reduces physician capital contribution but introduces a long-term operational partner whose incentives may diverge from the surgeons' over time.
• Sale-leaseback of real estate. Develop the facility, sell the building to a healthcare REIT or investor, and lease it back. Frees up capital tied to real estate; creates a NNN lease obligation. Common for larger, multi-OR facilities where real estate is a meaningful portion of total capital.

Federal and state regulatory pathway

State licensure

Every state requires an ASC to obtain a state license before opening. Licensing requirements vary by state but generally include: facility design approval, inspection, clinical policy review, and staff credentialing documentation. Your healthcare attorney will know the specific state agency (typically the Department of Health) and current timelines.

CMS Medicare certification

To bill Medicare Part B for facility fees, an ASC must be certified by CMS. The process: complete and submit Form 855B (Medicare enrollment application) with your Medicare Administrative Contractor. Once the 855B is approved, you must perform a minimum of 10 procedures before requesting an initial certification survey. The state health department conducts the survey on CMS's behalf; if no deficiencies are found, CMS certification is typically effective the survey date. The post-opening certification process commonly takes 3–6 months.⁴

Alternatively, accreditation by a CMS-approved organization grants "deemed status" — which means your accreditation survey substitutes for the state certification survey, streamlining the process.

Accreditation

The four main ASC accrediting bodies, all CMS-approved for deemed status, are:

• AAAHC (Accreditation Association for Ambulatory Health Care) — most commonly used by physician-owned ASCs; known for practical standards aligned with outpatient surgery workflows.
• The Joint Commission — higher name recognition, more complex standards; preferred by some hospital-affiliated facilities and payers.
• ACHC (Accreditation Commission for Health Care) — newer entrant, growing ASC presence.
• QUAD A (Institute for Medical Quality) — smaller but established, particularly common in California.

Most de novo orthopedic ASCs pursue AAAHC accreditation. The accreditation survey involves an on-site review of policies, procedures, medical records, and facility conditions. For a new facility, build in 6–12 months from opening to complete accreditation.

Payer contracting: the underrated critical path

The biggest thing most orthopedic surgeons underestimate about de novo ASC development is payer contracting. Without commercial insurance contracts in place, your facility can only bill Medicare rates or bill out-of-network — both of which typically cut projected revenue by 30–50% compared to contracted commercial rates.

Insurance contracting timelines are long. A major commercial payer (UnitedHealthcare, Aetna, BCBS, Cigna) can take 6–18 months to execute a new ASC contract. Each payer's process is independent. You cannot accelerate this by applying earlier than 3–6 months before projected opening; payers won't execute contracts for facilities that don't yet exist.

Contracting strategy considerations:

• Engage a healthcare attorney or ASC billing consultant experienced in payer contracting for your region before construction starts.
• Target contracting applications at 4–6 months before projected opening date.
• Budget for 3–6 months of out-of-network billing after opening while contracts finalize.
• Consider how your surgeon group's existing hospital privileges and individual payer relationships can support the facility contracting process — payers are more likely to contract an ASC whose surgeons are already in-network.

Self-managed vs. management company

An ASC management company handles billing, coding, credentialing, staffing, supply chain, compliance, and day-to-day operations. Management fees typically run 5–7% of net revenue. In return, you get experienced operators who have opened facilities before and know the regulatory and operational pitfalls.

Self-management is possible for experienced groups but requires hiring an ASC administrator (salary $100K–$180K), billing staff, and compliance personnel. The economics favor management companies early in a facility's life; experienced groups sometimes internalize management after 3–5 years of operation when the processes are stable.

The corporate partner model (USPI, Surgery Partners, AmSurg, SurgCenter Development) is distinct from a management-only arrangement: the corporate partner takes an equity stake, contributes capital, and handles management, but shares in distributions and has rights over major operational and strategic decisions. You gain a well-resourced operating partner; you give up some governance control and a portion of distributions.

Realistic development timeline

In non-CON states with a cooperative local regulatory environment, 18 months from concept to first case is achievable. In CON states with opposition, 36+ months is realistic. The table above reflects a non-CON-contested path.

Financial planning for the surgeon during development

The development period creates specific financial planning challenges that most advisors don't anticipate:

• Capital calls on a schedule. Your $400K–$700K equity contribution will be called in tranches — typically $100K–$200K at project milestones over 18–24 months. These calls must be planned around your existing cash flow, retirement contributions, and other capital deployments (ASC buy-in at another facility, practice buy-in, mortgage). Model these against your income calendar before committing.
• No distributions during development. You're writing capital checks while earning zero facility income. This is a 2-year period where your liquid savings must absorb both the capital calls and any interruption to clinical income.
• Retirement contribution continuity. Do not sacrifice Solo 401(k) / cash balance plan / backdoor Roth contributions during the development period to fund ASC capital calls. The tax-deferred compounding lost from skipping retirement contributions at $800K+ income is substantial. Budget both simultaneously.
• Financing vs. paying cash. Consider whether some or all of your capital contribution should be financed rather than paid from liquid savings. A physician-level personal loan or HELOC at 6–8% may be worth using if the alternative is liquidating tax-advantaged accounts or stopping retirement contributions. The post-opening IRR on an ASC investment commonly exceeds 20% — borrowing at 7% to earn 20% is favorable math.
• Insurance review. During the development period, review your own-occupation disability coverage. If you become disabled and can't operate, you can't contribute cases to your new ASC — which may trigger case-volume minimums in the operating agreement and affect your distribution rights. Disability policy language matters here.

What the financial model needs to show

Before committing capital, run a serious financial model — ideally with an advisor who has modeled ASC investments before. The model should project:

• Case volume ramp (months 1–36 to stabilization)
• Revenue per case by payer mix (Medicare rate vs. commercial contracted rate vs. out-of-network)
• Operating cost structure (staffing, supplies, rent/debt service, management fee, malpractice)
• Break-even case volume and month of first positive cash flow
• IRR on total physician equity investment over a 10-year hold
• Exit scenario: sale to corporate buyer at 6–10× EBITDA with rollover equity analysis

The ASC Investment ROI Calculator models the buy-in, distribution, and exit economics for an established facility. De novo development requires a more detailed projection model given the ramp-up period and uncertain revenue in months 1–12.

What a financial advisor should help you with

This decision — committing $400K–$700K of capital to a 2–3 year development project — is among the largest financial decisions most orthopedic surgeons make. A financial advisor with orthopedic practice experience should:

• Model the development capital calls against your existing cash flow and retirement contributions
• Evaluate financing vs. cash contribution trade-offs at your income and tax rate
• Stress-test the ASC financial model against realistic volume and payer-mix assumptions
• Review the operating agreement and distribution waterfall before you sign
• Integrate the ASC equity position into your overall portfolio (concentration risk, liquidity)
• Plan the eventual exit — corporate sale, hospital acquisition, or wind-down — from the beginning

Most generalist advisors have never seen an ASC operating agreement or modeled a distribution waterfall. The specialist matters here. See How to Choose a Financial Advisor for Orthopedic Surgeons.

1. CMS CY 2026 ASC Final Rule — 547 procedures added to the ASC Covered Procedures List, including additional orthopedic and spine procedures: CMS CY 2026 OPPS/ASC Final Rule Fact Sheet; Holland & Knight analysis of CY 2026 OPPS/ASC Final Rule.
2. CON state requirements for ASCs and 2025–2026 reform activity: Holland & Knight — Recent State and Federal Changes to ASC Regulatory Landscape (2025); NCSL Certificate of Need State Laws; HST Pathways — CON Laws for ASCs. State laws change; verify current CON status with a healthcare attorney before committing capital.
3. Anti-Kickback Statute safe harbor for ASC ownership: 42 C.F.R. § 1001.952(r) — ASC safe harbor provisions for single-specialty and multi-specialty facilities. OIG Advisory Opinion guidance. Reviewed as part of ASC operating agreement structuring with healthcare transactional counsel.
4. CMS Medicare initial certification process for ASCs: Minnesota Dept. of Health — Initial Medicare Certification Process for ASCs (reflects standard CMS process per 42 C.F.R. Part 416); Form 855B via CMS.gov. Minimum 10 procedures required before initial survey per CMS operational guidance.

Values verified as of June 2026. CON requirements, CMS procedures lists, and commercial lending rates change regularly. Engage a healthcare transactional attorney and an orthopedic-specialist financial advisor before committing capital to a de novo development project.